Research Article
Decitabine Compared with Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia: A Pilot Study of Safety, Efficacy, and Cost-Effectiveness
Figure 1
Kaplan-Meier survival curve. Treatment 1: decitabine. Treatment 2: low-dose cytarabine.